Variational AI will take part in Invest in BC 2026, the 11th annual conference presented by Lumira Ventures and hosted by Life Sciences BC, on November 3 and 4, 2026 at the Vancouver Convention Centre West. Invest in BC anchors Life Sciences Investment Week (November 2 to 5), a program of curated events bringing over 100 investors to Vancouver alongside entrepreneurs, researchers, and industry leaders. The conference includes keynotes, panel discussions, investor-ready company pitches, and partnering through the BIO Partnering™ system.
As a Vancouver company, this is our home venue. Variational AI is Canada’s only independent generative small-molecule platform, and our work with partners including Merck/MSD, Rakovina Therapeutics, and 3C Therapeutics is built and run from British Columbia.
Meet the team
Handol Kim, Co-Founder & CEO
Valentin Beuchillot, Director of Business Development & Marketing
We will be taking partnering meetings throughout the event to discuss AI-enabled lead finding and lead generation for programs in Korea and across the region.
Meet the team
If you are attending BIX 2026 or joining the Canadian delegation program, reach out to bd@variational.ai to schedule time. Meetings can also be requested through the BIX partnering platform.